Page last updated: 2024-09-03

pramipexole and d-alpha tocopherol

pramipexole has been researched along with d-alpha tocopherol in 3 studies

Compound Research Comparison

Studies (pramipexole)	Trials (pramipexole)	Recent Studies (post-2010) (pramipexole)	Studies (d-alpha tocopherol)	Trials (d-alpha tocopherol)	Recent Studies (post-2010) (d-alpha tocopherol)
1,103	219	517	32,198	2,903	7,258

Protein Interaction Comparison

Protein	Taxonomy	pramipexole (IC50)	d-alpha tocopherol (IC50)
Glutathione S-transferase P	Homo sapiens (human)		0.5

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Althaus, JS; Fici, GJ; VonVoigtlander, PF	1
Carvey, PM; Ling, ZD; Robie, HC; Tong, CW	1

Reviews

1 review(s) available for pramipexole and d-alpha tocopherol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for pramipexole and d-alpha tocopherol

Article	Year
Pharmacological approaches to counter the toxicity of Dopa. Amino acids, 1998, Volume: 14, Issue:1-3 Topics: Animals; Benzothiazoles; Cells, Cultured; Cerebellum; Cytoplasmic Granules; Glutathione; Levodopa; Neuroprotective Agents; Pramipexole; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Selegiline; Thiazoles; Vitamin E	1998
Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1 Topics: Animals; Antioxidants; Benzothiazoles; Cell Count; Cell Survival; Cells, Cultured; Culture Media, Conditioned; Dopamine Agents; Dopamine Agonists; Levodopa; Mesencephalon; Neuroprotective Agents; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Tyrosine 3-Monooxygenase; Vitamin E	1999

Article

Year

Pharmacological approaches to counter the toxicity of Dopa.

Amino acids, 1998, Volume: 14, Issue:1-3

Topics: Animals; Benzothiazoles; Cells, Cultured; Cerebellum; Cytoplasmic Granules; Glutathione; Levodopa; Neuroprotective Agents; Pramipexole; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Selegiline; Thiazoles; Vitamin E

1998

Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures.

The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1

Topics: Animals; Antioxidants; Benzothiazoles; Cell Count; Cell Survival; Cells, Cultured; Culture Media, Conditioned; Dopamine Agents; Dopamine Agonists; Levodopa; Mesencephalon; Neuroprotective Agents; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Tyrosine 3-Monooxygenase; Vitamin E

1999